Bendazac lysine reduces the affect of the cataract. References: Hockwin O, Laser H, De Gregorio M, Carrieri MP. Bendazac lysine in selected types of human senile cataract. A long-term double-masked placebo-controlled clinical trial with multilinear densitometric image analysis of Scheimpflug photographs. Ophthalmic Res. 1989;21(3):141-54. PubMed PMID: 2674821.

纯度：≥98%

CAS：81919-14-4